Influenza Vaccines: Clinical Trials

32 trials for Influenza Vaccines, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

22 completed, 2 active not recruiting, 2 not yet recruiting, 2 recruiting. 12 Phase 4, 8 Not applicable, 5 Phase 2, 4 Phase 3, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 412Completed 8, Active not recruiting 1, Not yet recruiting 1, Recruiting 1, Unknown 1
Not applicable8Completed 4, Active not recruiting 1, Not yet recruiting 1, Recruiting 1, Unknown 1
Phase 25Completed 3, Terminated 1, Withdrawn 1
Phase 34Completed 4
Phase 11Withdrawn 1

Follow Influenza Vaccines: new trials by email Literature Review of Influenza Vaccines trials Research Report on Influenza Vaccines

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Preoperative Pneumococcal and Influenza Vaccination to Prevent Postoperative Pulmonary Infection in Patients Undergoing Lung Resection for Pulmonary Nodules or Lung Cancer
23-valent pneumococcal polysaccharide vaccine, Quadrivalent split-virion influenza vaccine - Pneumococcal Polysaccharide Vaccine, Influenza Vaccines
Phase 4Not yet recruitingThe First Affiliated Hospital of Guangzhou Medical University12782026-11-012026-10-21
Vaccination Nudges From Pharmacists
Behavioural Nudge (Influenza Risk Reduction), Behavioural Nudge (Travel Vaccination Benefit) - Stroke, Influenza Human
Not applicableActive not recruitingUniversity of Calgary200002025-11-062026-02-10
Comparative Immunologic Mechanisms and Microbiome Interactions Following Different Influenza Vaccine Formulations in Older Adults
Standard-Dose Influenza Vaccine, MF59-Adjuvanted Influenza Vaccine, High-Dose Influenza Vaccine - Influenza, Influenza Vaccines
Phase 4CompletedKorea University Guro Hospital1212025-10-252026-09-04
Characterizing the Human Airway Immune Response to FluMist Vaccination
FluMist, inactivated influenza vaccine, bronchoscopy - Healthy Young Adults, Influenza Vaccines
Phase 4RecruitingWashington University School of Medicine302025-09-092025-09-17
Estimate the Safety and Effectiveness of Adjuvanted Influenza Vaccine Among Asian Elderly People When Compared to Non-adjuvanted Vaccines
adjuvanted, non-adjuvanted - Influenza Vaccines, Elderly
Not applicableRecruitingNational Taiwan University Hospital2002024-11-212026-02-24
Vaccine Chatbot for Improving Influenza Vaccination Uptake
An AI-enabled chatbot tailored for influenza vaccine consultation - Influenza Vaccines
Not applicableNot yet recruitingFudan University12002024-10-262024-10-24
Influenza Vaccine Uptake Among Healthcare Workers
ensuring the availability of influenza vaccine supply & developing influenza vaccine awareness - Influenza Vaccines
Not applicableUnknownInternational Centre for Diarrhoeal Disease Research, Bangladesh30002022-03-122022-09-15
Combined Immunization of COVID-19 Inactivated Vaccine With QIV and PPV23
Vaccine - Safety, Immunogenicity, Vaccine
Phase 4UnknownCenters for Disease Control and Prevention, China30002021-10-082022-03-28
Financing Strategies of Influenza Vaccination in China
No intervention - Influenza Vaccines, Influenza, Human
CompletedPeking University135422019-08-012022-01-24
A Pragmatic Assessment of Influenza Vaccine Effectiveness in the DoD
Egg based influenza vaccines, Recombinant influenza vaccines, Cell-culture based influenza vaccines - Influenza, Influenza-like Illness
Phase 4Active not recruitingHenry M. Jackson Foundation for the Advancement of Military Medicine154482018-11-062026-04-02
Assessment of Viral Shedding Week Following Administration of Live Attenuated Influenza Vaccine in Children
Live attenuated influenza vaccine (LAIV) - Influenza Vaccines
Phase 4CompletedImperial College London122018-10-232024-04-05
Centralized IIS-based Reminder/Recall to Increase Childhood Influenza Vaccination Rates_2nd Trial in Colorado
Reminders - Reminder Systems, Influenza Vaccines
Not applicableCompletedUniversity of Colorado, Denver255312017-09-062019-06-24
Active Surveillance for Adverse Events Following Immunization With the Influenza Vaccine Produced at Butantan Institute
Seasonal Influenza vaccine - Influenza Vaccines
CompletedButantan Institute5332017-04-062018-01-17
Study on the Effect of Influenza Vaccination After Heart Attack on Future Cardiovascular Prognosis
Influenza vaccine, Placebo - Myocardial Infarction, Influenza, Human
Phase 4CompletedOle Frobert, MD, PhD25712016-10-012021-09-22
Centralized IIS-based Reminder/Recall to Increase Childhood Influenza Vaccination Rates
Reminder notifications via autodialer - Reminder Systems, Influenza Vaccines
Not applicableCompletedUniversity of Colorado, Denver565492016-09-012019-06-24
Adjuvanted Influenza Vaccine in Stem Cell Transplant
FLUADĀ® influenza vaccine, FLUVIRALĀ® - Transplantation, Influenza Vaccines
Phase 4CompletedUniversity Health Network, Toronto732015-10-012017-04-10
Attitudes Toward Human Papillomavirus and Influenza Vaccination Among Mothers of Early Adolescents
Provider Communication about Vaccination - Human Papillomavirus Vaccines, Influenza Vaccines
Not applicableCompletedIndiana University11652014-08-012023-10-31
Safety and Tolerability Study of GlaxoSmithKline (GSK)1557484A Vaccine in Adults at Occupational Risk for Influenza A (H5N1) Exposure
Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted (A/Indonesia) - Influenza, Influenza Vaccines
Phase 3CompletedGlaxoSmithKline502013-03-222020-06-23
MAS-1 Adjuvanted Compared to Unadjuvanted Influenza Vaccines in the Elderly
MAS-1 adjuvant and influenza HA antigen, standard dose, inactivated trivalent influenza vaccine (TIV) - Influenza Vaccines, Aged
Phase 1 / Phase 2WithdrawnUS Department of Veterans Affairs2012-10-012012-09-26
Monovalent H5N1 Vaccine GSK1557484A in Children 6 Months to < 18 Years of Age
Influenza A (H5N1) Virus monovalent vaccine, Saline placebo - Influenza, Influenza Vaccines
Phase 3CompletedGlaxoSmithKline8422011-03-072021-11-01

Showing 20 of 32. Sign in to see all of them.

Narrower conditions

Influenza, Human (32)  ·  Stroke (2)  ·  Behavior (1)  ·  Heart Failure (1)  ·  Myocardial Infarction (1)  ·  Travel-Related Illness (1)

Broader conditions

Infections (32)  ·  Orthomyxoviridae Infections (32)  ·  RNA Virus Infections (32)  ·  Respiratory Tract Diseases (32)  ·  Respiratory Tract Infections (32)  ·  Virus Diseases (32)  ·  Brain Diseases (2)  ·  Cardiovascular Diseases (2)  ·  Central Nervous System Diseases (2)  ·  Cerebrovascular Disorders (2)  ·  Nervous System Diseases (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Vascular Diseases (2)  ·  Heart Diseases (1)  ·  Infarction (1)

Interventions

Influenza Vaccines (9)  ·  fluarix (2)  ·  23-valent pneumococcal capsular polysaccharide vaccine (1)  ·  Bronchoscopy (1)  ·  FluMist (1)  ·  GBP510 vaccine (1)  ·  Vaccines (1)  ·  vaxigrip (1)

Sponsors

GlaxoSmithKline (8)  ·  University Health Network, Toronto (2)  ·  University of Colorado, Denver (2)  ·  Abbott Biologicals (1)  ·  Butantan Institute (1)  ·  Centers for Disease Control and Prevention, China (1)  ·  Centers for Disease Control, Taiwan (1)  ·  Fudan University (1)  ·  HaEmek Medical Center, Israel (1)  ·  Henry M. Jackson Foundation for the Advancement of Military Medicine (1)  ·  Imperial College London (1)  ·  Indiana University (1)  ·  International Centre for Diarrhoeal Disease Research, Bangladesh (1)  ·  Korea University Guro Hospital (1)  ·  National Taiwan University Hospital (1)

Countries

United States (7)  ·  Canada (6)  ·  China (3)  ·  Taiwan (3)  ·  Bangladesh (2)  ·  Czechia (2)  ·  Germany (2)  ·  Thailand (2)  ·  United Kingdom (2)  ·  Australia (1)  ·  Brazil (1)  ·  Denmark (1)  ·  Estonia (1)  ·  Hong Kong (1)  ·  Israel (1)

Top investigators

Allison Kempe, MD, MPH (2)  ·  Deepali Kumar, MD (2)  ·  Alfonso Iorio (1)  ·  Amity Quinn (1)  ·  Anna Maria Iorio (1)  ·  Dan Miron, MD (1)  ·  Geoffrey J. Gorse, MD (1)  ·  Gregory D Zimet, PhD (1)  ·  Hai Fang, PhD (1)  ·  Hanka de Voogd, MD (1)  ·  Ian Skurnik, PhD (1)  ·  Jen-Hsiang Chunag, MD, MS, PhD. (1)  ·  Joon Young Song, MD, PhD (1)  ·  Lily Weckx, MD (1)

Results publications

PMID 17544181, PMID 19245312, PMID 20386004, PMID 23237154, PMID 24968160, PMID 25618790, PMID 25789200, PMID 25896384, PMID 27658738, PMID 28410814, PMID 29753361, PMID 29801998, PMID 30570077, PMID 30964934, PMID 31698085, PMID 32446470, PMID 34459211, PMID 36153529, PMID 38140184, PMID 39229259, PMID 40973113, PMID 42688087

NIH funding

2009 (1), 2018 (1)